|
|
Antwerp BE / Paris FR, 16 November 2018, 07:30 CET embargo
Gimv in exclusive negotiations with Industries & Finances to
become majority shareholder of Groupe Claire
Gimv will be acquiring a majority stake in Groupe Claire, alongside its management, in order to
support the company’s development in France and abroad, both with its traditional as well as with
... See more |
|
| |
|
| |
|
|
Antwerp BE, 15 November 2018, 7:30 AM CET embargo
Gimv invests in Belgian biotech company CamelIDS, to support
its unique radioimmunotherapy platform
CamelIDS, a Brusselsbased company developing cancertargeted radiopharmaceuticals
today announced the completion of a seriesA financing round, whereby the company
secured funding of EUR 37 million. Gimv,... See more |
|
| |
|
| |
|
|
Gimv enters into exclusivity with Cerea Capital II to become majority
shareholder of La Comtoise alongside the company’s Chairman and
founder
Gimv will acquire a majority interest in La Comtoise, alongside Michel Vanhove and the management team, to
support the company in its growth and... See more |
|
| |
|
| |
|
|
Gimv acquires MediMarkt Homecare Service and Medi
Markt Service Nord Ost: market leadership in medical
supplies to be further expanded after the merger
As part of a succession plan, Gimv is investing in the two German companies MediMarkt Homecare
Service GmbH and Medi Markt Service Nord Ost GmbH as well as a number of affiliated
companies. These two leading... See more |
|
| |
|
| |
|
|
Antwerp, 19 July 2018, 07:00 CET EMBARGO
Business update
First three months of the 2018/2019 financial year
As well as publishing halfyearly and annual results, Gimv also provides quarterly business updates without
publishing full results.
The figures below cover the period from 1 April 2018 to 30 June 2018. All figures refer to the
consolidated... See more |
|
| |
|
| |
|
|
Search :
